ETI
GILD icon

Enterprise Trust & Investment’s Gilead Sciences GILD Stock Holding History

Enterprise Trust & Investment’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.22M Sell
19,750
-50
-0.3% -$3.1K 0.51% 55
2022
Q1 		$1.18M Sell
19,800
-900
-4% -$57.5K 0.42% 56
2021
Q4 		$1.5M Sell
20,700
-250
-1% -$17.2K 0.53% 49
2021
Q3 		$1.46M Sell
20,950
-100
-0.5% -$7.03K 0.59% 47
2021
Q2 		$1.45M Sell
21,050
-100
-0.5% -$6.68K 0.59% 49
2021
Q1 		$1.37M Sell
21,150
-200
-0.9% -$12.9K 0.61% 47
2020
Q4 		$1.32M Sell
21,350
-350
-2% -$21.1K 0.63% 45
2020
Q3 		$1.37M Sell
21,700
-100
-0.5% -$6.93K 0.77% 34
2020
Q2 		$1.68M Buy
21,800
+2,850
+15% +$218K 1% 32
2020
Q1 		$1.42M Sell
18,950
-150
-0.8% -$10.4K 0.99% 32
2019
Q4 		$1.24M Sell
19,100
-100
-0.5% -$6.51K 0.69% 41
2019
Q3 		$1.22M Sell
19,200
-900
-4% -$58.8K 0.75% 41
2019
Q2 		$1.36M Buy
+20,100
New +$1.32M 0.84% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Enterprise Trust & Investment's GILD Position: Q2 2022 in Review

Enterprise Trust & Investment reduced its Gilead Sciences (GILD) stake by 0.25% in Q2 2022, selling an estimated $3.1K and leaving 19,750 shares worth $1.22M. The position accounts for 0.51% of the portfolio, ranked #55.

Enterprise Trust & Investment first reported a position in GILD in Q2 2019 and has held it in 13 quarters since. The position peaked at $1.68M in Q2 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Enterprise Trust & Investment held 19,750 shares of Gilead Sciences worth $1.22M as of Q2 2022.
  • Enterprise Trust & Investment sold 50 Gilead Sciences shares in Q2 2022, an estimated $3.1K.
  • Gilead Sciences made up 0.51% of Enterprise Trust & Investment's portfolio in Q2 2022, its #55 holding.
  • Enterprise Trust & Investment first reported a position in Gilead Sciences in Q2 2019 and has held it in 13 quarters since.
  • Enterprise Trust & Investment's Gilead Sciences position peaked at $1.68M in Q2 2020.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.